Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2025-12-24 @ 11:38 PM
NCT ID:
NCT01795456
Eligibility Criteria:
Inclusion Criteria:
* Male and female patients \>18 years
* Diagnosis of Takayasu's arteritis or giant cell arteritis
* Suspicion of common carotid involvement on the basis of physical examination (cervical bruit), carotidynia, documented CCA involvement on an imaging study (MRA, CTA, or ultrasound), or documented upper extremity large vessel involvement on an imaging study (MRA or CTA or ultrasound).
* Ability to provide informed consent
Exclusion Criteria:
* Prior stroke, carotid surgery or angioplasty
* Pregnant (or trying to become pregnant)
* Nursing
* Known or suspected cardiac shunt
* Documented hypersensitivity to the contrast agent
* Severe pulmonary hypertension or unstable cardiopulmonary conditions (acute myocardial infarction, acute coronary artery syndromes, worsening or unstable congestive heart failure, serious ventricular arrhythmias, or respiratory failure)
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT01795456
Study Brief:
Protocol Section:
NCT01795456